BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 19/11/2024

FDA Clears Path for Abbreviated New Drug Applications for HYDROCORTONE Injection

The FDA has determined that HYDROCORTONE (hydrocortisone sodium phosphate) injection, equivalent to 50 milligrams base/milliliter, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for this product.

Source: Federal Register — Food and Drug AdministrationOpen original release →